- Home
- ALLR vs ADIL Comparison
ALLR vs ADIL Comparison
Compare ALLR & ADIL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ALLR
- ADIL
- Stock Information
- Founded
- ALLR 2004
- ADIL 2010
- Country
- ALLR United States
- ADIL United States
- Employees
- ALLR N/A
- ADIL N/A
- Industry
- ALLR Biotechnology: Pharmaceutical Preparations
- ADIL Biotechnology: Pharmaceutical Preparations
- Sector
- ALLR Health Care
- ADIL Health Care
- Exchange
- ALLR Nasdaq
- ADIL Nasdaq
- Market Cap
- ALLR 15.8M
- ADIL 6.0M
- IPO Year
- ALLR N/A
- ADIL 2018
- Fundamental
- Price
- ALLR $0.94
- ADIL $0.38
- Analyst Decision
- ALLR Strong Buy
- ADIL Strong Buy
- Analyst Count
- ALLR 1
- ADIL 1
- Target Price
- ALLR $9.00
- ADIL $8.00
- AVG Volume (30 Days)
- ALLR 367.8K
- ADIL 3.5M
- Earning Date
- ALLR 08-15-2025
- ADIL 08-13-2025
- Dividend Yield
- ALLR N/A
- ADIL N/A
- EPS Growth
- ALLR N/A
- ADIL N/A
- EPS
- ALLR N/A
- ADIL N/A
- Revenue
- ALLR N/A
- ADIL N/A
- Revenue This Year
- ALLR N/A
- ADIL N/A
- Revenue Next Year
- ALLR N/A
- ADIL N/A
- P/E Ratio
- ALLR N/A
- ADIL N/A
- Revenue Growth
- ALLR N/A
- ADIL N/A
- 52 Week Low
- ALLR $0.61
- ADIL $0.22
- 52 Week High
- ALLR $6.00
- ADIL $1.30
- Technical
- Relative Strength Index (RSI)
- ALLR 47.03
- ADIL 44.32
- Support Level
- ALLR $0.85
- ADIL $0.35
- Resistance Level
- ALLR $1.01
- ADIL $0.41
- Average True Range (ATR)
- ALLR 0.05
- ADIL 0.03
- MACD
- ALLR -0.01
- ADIL -0.00
- Stochastic Oscillator
- ALLR 47.55
- ADIL 27.36
About ALLR Allarity Therapeutics Inc.
Allarity Therapeutics Inc is a clinical-stage, precision medicine pharmaceutical company focused on developing novel anti-cancer therapeutics for patients with high unmet medical needs. The company is actively advancing the development of stenoparib, an orally available, small-molecule inhibitor for patients with advanced recurrent ovarian cancer. It is leveraging its proprietary Drug Response Predictor (DRP) technology to refine patient selection and improve clinical outcomes. The company operates as a single operating and reporting segment (developing a treatment for ovarian cancer) in two geographic areas: Denmark and the United States.
About ADIL Adial Pharmaceuticals Inc
Adial Pharmaceuticals Inc is a clinical-stage biopharmaceutical company. The company develops prescription medications for addiction and related disorders. Its lead product is AD04, which is for the treatment of alcohol use disorder. The active ingredient in AD04 is ondansetron, a serotonin-3 antagonist.